Lyme meningoradiculitis: prospective evaluation of biological diagnosis methods

  • F. Roux
  • E. Boyer
  • B. Jaulhac
  • E. Dernis
  • F. Closs-Prophette
  • X. PuéchalEmail author


The symptoms of Lyme meningoradiculitis and the value of biological examinations in an endemic area were determined in a prospective study in which data were collected on all patients consecutively hospitalised for Lyme meningoradiculitis at our institution during an 18-month period. Specific antibody titres in the serum and cerebrospinal fluid (CSF) were determined by Vidas enzyme-linked-immunosorbent-assay (IgG + IgM), Dade-Behring enzyme immunoassay (EIA) (IgM; IgG) and Western blot analysis (IgG). We also searched for Borrelia burgdorferi in the CSF by PCR analysis and following culture on a specific medium. A control group was recruited, consisting of 16 consecutive patients who had been referred during the same period with suspected but not confirmed Lyme meningoradiculitis. Eleven patients were included. Borrelia EIA of the serum revealed that 40% of the patients had both elevated specific IgM titres and intrathecal synthesis of specific IgG; 40% of the patients was negative for IgM but had isolated intrathecal synthesis of IgG; 20% of the patients had elevated specific IgM titres without intrathecal synthesis of IgG. PCR analysis and the CSF culture were positive in one case only (B. garinii). The results of this study highlight the importance of systematic serological testing for B. burgdorferi in the CSF in the case of early neuroborreliosis suspicion, even in the absence of IgM serum antibodies, which was the case in 40% of the patients in the present study. Nevertheless, intrathecal anti-B. burgdorferi IgG synthesis, which remains the “gold standard” for the diagnosis of neuroborreliosis, was not detectable in 20% of the patients for whom diagnosis was subsequently confirmed by demonstration of specific serum IgM.


Lyme Disease Borrelia Burgdorferi Lyme Borreliosis Erythema Migrans Tick Bite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank C. Barthel and E. Collin for excellent technical assistance.


  1. 1.
    Steere AC (2001) Lyme disease. N Engl J Med 345:115–125PubMedCrossRefGoogle Scholar
  2. 2.
    Garcia-Monco JC, Benach JL (1995) Lyme neuroborreliosis. Ann Neurol 37:691–702PubMedCrossRefGoogle Scholar
  3. 3.
    Wang G, Van Dam AP, Schwartz I, Dankert J (1999) Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological and clinical implications. Clin Microbiol Rev 12:633–653PubMedGoogle Scholar
  4. 4.
    Nadelman RB, Wormser GP (1998) Lyme borreliosis. Lancet 352:557–565PubMedCrossRefGoogle Scholar
  5. 5.
    Sigal LH (1998) Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum 41:195–204PubMedCrossRefGoogle Scholar
  6. 6.
    Tugwell P, Dennis DT, Weinstein A, et al (1997) Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 127:1109–1123PubMedGoogle Scholar
  7. 7.
    Jespersen DJ, Smith TF, Rosenblatt JE, Cockerill FR 3rd (2002) Comparison of the Borrelia DotBlot G, MarDx, and VIDAS enzyme immunoassays for detecting immunoglobulin G antibodies to Borrelia burgdorferi in human serum. J Clin Microbiol 40:4782–4784PubMedCrossRefGoogle Scholar
  8. 8.
    Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B (1985) Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 21:819–825PubMedGoogle Scholar
  9. 9.
    Wilske B, Schierz G, Preac-Mursic V, Von Busch K, Kühbeck R, Pfister HW, Einhäupl K (1986) Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth’s syndrome). J Infect Dis 153:304–314PubMedGoogle Scholar
  10. 10.
    Hansen K, Lebech AM (1992) The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985–1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 115:399–423PubMedCrossRefGoogle Scholar
  11. 11.
    Kaiser R, Lucking CH (1993) Intrathecal synthesis of specific autibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118:64–72PubMedCrossRefGoogle Scholar
  12. 12.
    Dressler F, Whalen JA, Reinhardt BN, Steere AC (1993) Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167:392–400PubMedGoogle Scholar
  13. 13.
    Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G (1990) Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 28:473–479PubMedGoogle Scholar
  14. 14.
    Halperin JJ, Volkman DJ, Wu P (1991) Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41:1571–1582PubMedGoogle Scholar
  15. 15.
    Zbinden R, Goldenberger D, Lucchini GM, Altwegg M (1994) Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 32:1795–1798PubMedGoogle Scholar
  16. 16.
    Tumani H, Nolker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45:1663–1670PubMedGoogle Scholar
  17. 17.
    Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, Guy E, Gray J (1996) European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108:741–747PubMedGoogle Scholar
  18. 18.
    Pierer K, Stunzner D, Feichtinger M, Homann CN, Kleinert G, Kessler HH, Marth E (1999) Is IgM of diagnostic value in case of delayed intrathecal production of IgG antibodies ? Wien Klin Wochenschr 111:957–960PubMedGoogle Scholar
  19. 19.
    Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR, Caruso G, Cinco M, Fournier PE, Francavilla E, Jensenius M, Kazar J, Laferl H, Lakos A, Lotric Furlan S, Maurin M, Oteo JA, Parola P, Perez-Eid C, Peter O, Postic D, Raoult D, Tellez A, Tselentis Y, Wilske B (2004) ESCMID Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella. European Network for Surveillance of Tick-Borne Diseases. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 10:1108–1132PubMedCrossRefGoogle Scholar
  20. 20.
    Pfister HW, Wilske B, Weber K (1994) Lyme borreliosis: basic science and clinical aspects. Lancet 343:1013–1016PubMedCrossRefGoogle Scholar
  21. 21.
    Dhôte R, Basse-Guérineau AL, Beaumesnil V, Christoforov B, Assous MV (2000) Full spectrum of clinical, serological and epidemiological features of complicated forms of Lyme borreliosis in the Paris, France area. Eur J Clin Microbiol Infect Dis 19:809–815CrossRefGoogle Scholar
  22. 22.
    Centers for Disease Control and Prevention (1995) Recommendations for test performance and interpretation from the Second National Conference Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 44:590–591Google Scholar
  23. 23.
    Centers for Disease Control and Prevention (1997) Case definition for infections conditions under Public Health Surveillance: Lyme Disease (revised 9/96). Morb Mortal Wkly Rep 46:26–27Google Scholar
  24. 24.
    European Union Concerted on Lyme Borreliosis (EUCALB). URL:
  25. 25.
    Jaulhac B, Heller R, Limbach FX, Hansmann Y, Lipsker D, Monteil H et al. (2000) Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with Lyme arthritis. J Clin Microbiol 38:1895–1900PubMedGoogle Scholar
  26. 26.
    Garin C, Bujadoux C (1922) Paralysie par les tiques. J Med Lyon 71:765–767Google Scholar
  27. 27.
    Bannwarth A (1941) Chronishe lymphocytäre meningitis, entzündliche polyneuritis und rheumatismus. Arch Psychiatr Nervenkr 113:284–376CrossRefGoogle Scholar
  28. 28.
    Pachner AR, Steere AC (1985) The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 35:47–53PubMedGoogle Scholar
  29. 29.
    Robertson J, Guy E, Andrews N, Wilske B, Anda P, Granstrom M, Hauser U, Moosmann Y, Sambri V, Schellekens J, Stanek G, Gray J (2000) A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol 38:2097–2102PubMedGoogle Scholar
  30. 30.
    Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R (1990) Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 161:1203–1209PubMedGoogle Scholar
  31. 31.
    Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W et al. (1983) The spirochetal etiology of Lyme disease. N Engl J Med 308:733–742PubMedCrossRefGoogle Scholar
  32. 32.
    Pachner AR, Delaney E (1993) The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis. Ann Neurol 34:544–550PubMedCrossRefGoogle Scholar
  33. 33.
    Nocton JJ, Bloom BJ, Rutledge BJ, Persing DH, Logigian EL, Schmid CH et al. (1996) Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 174:623–627PubMedGoogle Scholar
  34. 34.
    Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, Kunkel M, Dattwyler RJ (1992) Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 267:1364–1367. Erratum in: JAMA 1992;268:872Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • F. Roux
    • 1
  • E. Boyer
    • 2
  • B. Jaulhac
    • 3
  • E. Dernis
    • 1
  • F. Closs-Prophette
    • 1
  • X. Puéchal
    • 1
    Email author
  1. 1.Service de RhumatologieCentre Hospitalier du MansLe MansFrance
  2. 2.Département de MicrobiologieCentre Hospitalier du MansLe MansFrance
  3. 3.Laboratoire de BactériologieHôpitaux Universitaires de StrasbourgStrasbourgFrance

Personalised recommendations